Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2003
12/17/2003EP1370549A1 Methods for the preparation of mirtazapine intermediates
12/17/2003EP1370506A1 Production of fluorine compounds
12/17/2003EP1370261A2 New use
12/17/2003EP1370211A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
12/17/2003EP1246825B1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
12/17/2003EP1218380B1 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
12/17/2003EP1202977B1 Process for manufacturing diazepine derivatives
12/17/2003CN1462435A Optical data carrier containing phthalocyanine colouring agent as light absorbing compound in information layer
12/17/2003CN1462303A Double-spiro organic compounds and electric-field luminescent devices
12/17/2003CN1462273A Bicyclic heteroaromatic compounds
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/17/2003CN1462193A Oral preparations
12/16/2003US6664400 1-((4-halo-3-sulfonamidophenyl)aminocarbonyl),2-carboxy -pyrrolidine intermediate of given formula
12/16/2003US6664396 One step synthesis for quinacridone compounds
12/16/2003US6664282 Synthesis of [3,5,7]-1H-imidazo [1,5-a]imidazol-2 (3H)- one compounds
12/16/2003US6664261 Pyrazolopyrimidines as CRF receptor antagonists
12/16/2003US6664252 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664058 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels
12/16/2003CA2178272C Antiviral monocyclic polyamines
12/11/2003WO2003101999A2 Preparation of metal mesoporphyrin halide compounds
12/11/2003WO2003101993A1 Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents
12/11/2003WO2003101968A1 Pyrazole compound and medicinal composition containing the same
12/11/2003WO2003101456A1 Use of compounds that stimulate cgmp
12/11/2003WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/11/2003WO2003101442A1 Peptide deformylase inhibitors
12/11/2003WO2003033500B1 Photoactivable nitrogen bases
12/11/2003WO2002088114A3 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
12/11/2003WO2002073062B1 Synthetic molecular spring device
12/11/2003WO2002060383A3 Cancer therapy
12/11/2003US20030229131 Separation; nonlinear responce; optical recording media; filter
12/11/2003US20030229108 Angiogenesis inhibitors; antitumor agents, anticancer agents
12/11/2003US20030229104 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines
12/11/2003US20030229095 Sexual disorders
12/11/2003US20030229089 Cyclic compounds
12/11/2003US20030229084 Osteoporosis; antiarthritic agents
12/11/2003US20030229077 Nitrogen-containing heterocyclic compounds
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/11/2003US20030229071 Solvent extraction, separation, crystallization
12/11/2003US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders
12/11/2003US20030229026 Agents and methods for the treatment of proliferative diseases
12/11/2003US20030229002 Use of agents that modulate PDE11A activity
12/11/2003US20030226996 Organic semiconductor material and organic electronic device
12/11/2003CA2487905A1 Use of cgmp - stimulating compounds
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/11/2003CA2454654A1 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/10/2003EP1369421A1 Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives
12/10/2003EP1368579A2 Synthetic molecular spring device
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003EP1368353A1 2-alkoxyphenyl substituted imidazotriazinones
12/10/2003EP1368352A1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
12/10/2003EP1368351A2 7-(r)-amino-triazolopyrimidines, the production thereof and use of the same for combating phytopathogenic fungi
12/10/2003EP1368348A1 Novel 2,5-diazabicyclo(2.2.1)heptane derivatives
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
12/10/2003EP1368034A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1123936B1 Fused pyridazine derivatives, process for the preparation of the same and uses thereof
12/10/2003EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
12/10/2003EP0970086B1 Spiro compounds and the use thereof
12/10/2003EP0901374B1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
12/10/2003CN1130598C Photographic element containing magenta colour coupler having improved manufacturability and dye light stability
12/10/2003CN1130364C Deuteroporphyvin derivative, its preparing method and freeze dried preparation for injection
12/09/2003US6660856 Synthesis of pyrrolo[2,1-c][1,4]benzodiazepine analogues
12/09/2003US6660845 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
12/09/2003US6660748 1-azabicyclo(2.2.1)heptane or quinuclidine derivatives; treating or preventing neuronal damage associated with neurological diseases
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660731 Pyrazole compounds useful as protein kinase inhibitors
12/09/2003CA2078758C 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
12/06/2003CA2389634A1 Fused tri-heterocyclic compounds
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099821A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
12/04/2003WO2003099813A1 Novel physiolgically active substances
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099286A1 Pyrrolotriazinone compounds and their use to treat diseases
12/04/2003WO2003074526A3 Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography
12/04/2003WO2003070728A3 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
12/04/2003WO2003057667A3 Strapped and modified bis (benzimidazole) diamides for asymmetric catalysts and other applications
12/04/2003WO2003024946A3 Oxamate derivatives containing a variously substituted nitrogen heterocycle
12/04/2003WO2002094796A3 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
12/04/2003WO2002094186A3 Urazole compounds useful as anti-inflammatory agents
12/04/2003WO2002012241A8 Compounds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated diseases or dysfunction
12/04/2003US20030225280 2-Amino-N-(1(R)-benzvloxymethyl-2-(1,3-dioxo-8a(S)-pyridin-2-y lmethyl-2-(2,2,2-trifluoro-ethyl)-hexahydroimidazo(1,5-a)pyraz in-7-yl)-2-oxo- ethyl)-2-methyl-propionamide chloride from piperazine-2-carboxylate esters
12/04/2003US20030225271 Compounds useful as reversible inhibitors of cysteine proteases
12/04/2003US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225268 Diazabicyclic CNS active agents
12/04/2003US20030225264 Forming a novel mesoporphyrin IX intermediate compound (diformic salt) by catalytic hydrogenation of hemin and then converting the mesoporphyrin IX intermediate to metal mesophorphyrin halide through metal insertion
12/04/2003US20030225113 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies.
12/04/2003US20030225111 Use of a quinazoline derivative such as 1-(2,6-dichloro-phenyl)-3-(7-(3-morpholinopropoxy)quinazolin-4-yl) urea to produce an antiangiogenic and/or vascular permeability reducing effect
12/04/2003US20030225100 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
12/04/2003US20030225098 Pyrazolopyrmidine, isoxazolopyridimidine and furopyrimidine analogs; e.g, 3-(4-nitrophenyl)isoxazolo(5,4-d)pyrimidin-4-amine
12/04/2003US20030225096 Administering a growth hormone secretagogue.
12/04/2003US20030225090 Oxindole derivatives
12/04/2003US20030225073 Compositions useful as inhibitors of protein kinases
1 ... 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 ... 573